Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Mol Pharmacol
2014 Nov 01;865:548-60. doi: 10.1124/mol.114.094516.
Show Gene links
Show Anatomy links
Structural determinants and mechanism of action of a GluN2C-selective NMDA receptor positive allosteric modulator.
Khatri A
,
Burger PB
,
Swanger SA
,
Hansen KB
,
Zimmerman S
,
Karakas E
,
Liotta DC
,
Furukawa H
,
Snyder JP
,
Traynelis SF
.
???displayArticle.abstract???
NMDA receptors are tetrameric complexes of GluN1, GluN2A-D, and GluN3A-B subunits and are involved in normal brain function and neurologic disorders. We identified a novel class of stereoselective pyrrolidinone (PYD) positive allosteric modulators for GluN2C-containing NMDA receptors, exemplified by methyl 4-(3-acetyl-4-hydroxy-1-[2-(2-methyl-1H-indol-3-yl)ethyl]-5-oxo-2,5-dihydro-1H-pyrrol-2-yl)benzoate. Here we explore the site and mechanism of action of a prototypical analog, PYD-106, which at 30 μM does not alter responses of NMDA receptors containing GluN2A, GluN2B, and GluN2D and has no effect on AMPA [α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid] and kainate receptors. Coapplication of 50 μM PYD-106 with a maximally effective concentration of glutamate and glycine increases the response of GluN1/GluN2C NMDA receptors in HEK-293 cells to 221% of that obtained in the absence of PYD (taken as 100%). Evaluation of the concentration dependence of this enhancement revealed an EC50 value for PYD of 13 μM. PYD-106 increased opening frequency and open time of single channel currents activated by maximally effective concentrations of agonist but only had modest effects on glutamate and glycine EC50. PYD-106 selectively enhanced the responses of diheteromeric GluN1/GluN2C receptors but not triheteromeric GluN1/GluN2A/GluN2C receptors. Inclusion of residues encoded by GluN1-exon 5 attenuated the effects of PYD. Three GluN2C residues (Arg194, Ser470, Lys470), at which mutagenesis virtually eliminated PYD function, line a cavity at the interface of the ligand binding and the amino terminal domains in a homology model of GluN1/GluN2C built from crystallographic data on GluN1/GluN2B. We propose that this domain interface constitutes a new allosteric modulatory site on the NMDA receptor.
Acker,
Mechanism for noncompetitive inhibition by novel GluN2C/D N-methyl-D-aspartate receptor subunit-selective modulators.
2011, Pubmed
Acker,
Mechanism for noncompetitive inhibition by novel GluN2C/D N-methyl-D-aspartate receptor subunit-selective modulators.
2011,
Pubmed
Akazawa,
Differential expression of five N-methyl-D-aspartate receptor subunit mRNAs in the cerebellum of developing and adult rats.
1994,
Pubmed
Balu,
Neuroplasticity signaling pathways linked to the pathophysiology of schizophrenia.
2011,
Pubmed
Bettini,
Identification and characterization of novel NMDA receptor antagonists selective for NR2A- over NR2B-containing receptors.
2010,
Pubmed
Binshtok,
NMDA receptors in layer 4 spiny stellate cells of the mouse barrel cortex contain the NR2C subunit.
2006,
Pubmed
Cathala,
Developmental profile of the changing properties of NMDA receptors at cerebellar mossy fiber-granule cell synapses.
2000,
Pubmed
Chazot,
Molecular characterization of N-methyl-D-aspartate receptors expressed in mammalian cells yields evidence for the coexistence of three subunit types within a discrete receptor molecule.
1994,
Pubmed
Chen,
Modulation of glycine potency in rat recombinant NMDA receptors containing chimeric NR2A/2D subunits expressed in Xenopus laevis oocytes.
2008,
Pubmed
,
Xenbase
Clarke,
NMDA receptor NR2 subunit dependence of the slow component of magnesium unblock.
2006,
Pubmed
Collingridge,
The NMDA receptor as a target for cognitive enhancement.
2013,
Pubmed
Costa,
A novel family of negative and positive allosteric modulators of NMDA receptors.
2010,
Pubmed
,
Xenbase
Costa,
Structure-activity relationships for allosteric NMDA receptor inhibitors based on 2-naphthoic acid.
2012,
Pubmed
,
Xenbase
Dravid,
Structural determinants of D-cycloserine efficacy at the NR1/NR2C NMDA receptors.
2010,
Pubmed
,
Xenbase
Edgar,
MUSCLE: a multiple sequence alignment method with reduced time and space complexity.
2004,
Pubmed
Endele,
Mutations in GRIN2A and GRIN2B encoding regulatory subunits of NMDA receptors cause variable neurodevelopmental phenotypes.
2010,
Pubmed
Erreger,
Allosteric interaction between zinc and glutamate binding domains on NR2A causes desensitization of NMDA receptors.
2005,
Pubmed
Erreger,
Subunit-specific agonist activity at NR2A-, NR2B-, NR2C-, and NR2D-containing N-methyl-D-aspartate glutamate receptors.
2007,
Pubmed
,
Xenbase
Farrant,
NMDA-receptor channel diversity in the developing cerebellum.
1994,
Pubmed
Friesner,
Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes.
2006,
Pubmed
Gielen,
Mechanism of differential control of NMDA receptor activity by NR2 subunits.
2009,
Pubmed
Goff,
Dose-finding trial of D-cycloserine added to neuroleptics for negative symptoms in schizophrenia.
1995,
Pubmed
Goff,
Once-weekly D-cycloserine effects on negative symptoms and cognition in schizophrenia: an exploratory study.
2008,
Pubmed
Gottlieb,
D-cycloserine facilitation of cognitive behavioral therapy for delusions in schizophrenia.
2011,
Pubmed
Hallett,
Rationale for and use of NMDA receptor antagonists in Parkinson's disease.
2004,
Pubmed
Hansen,
Distinct functional and pharmacological properties of Triheteromeric GluN1/GluN2A/GluN2B NMDA receptors.
2014,
Pubmed
,
Xenbase
Hansen,
Control of assembly and function of glutamate receptors by the amino-terminal domain.
2010,
Pubmed
Hansen,
Structural and mechanistic determinants of a novel site for noncompetitive inhibition of GluN2D-containing NMDA receptors.
2011,
Pubmed
,
Xenbase
Hansen,
Subunit-selective allosteric inhibition of glycine binding to NMDA receptors.
2012,
Pubmed
Hansen,
Structural determinants of agonist efficacy at the glutamate binding site of N-methyl-D-aspartate receptors.
2013,
Pubmed
,
Xenbase
Hatton,
Modulation of triheteromeric NMDA receptors by N-terminal domain ligands.
2005,
Pubmed
,
Xenbase
Hillman,
Behavioral analysis of NR2C knockout mouse reveals deficit in acquisition of conditioned fear and working memory.
2011,
Pubmed
Hollmann,
Zinc potentiates agonist-induced currents at certain splice variants of the NMDA receptor.
1993,
Pubmed
,
Xenbase
Ishii,
Molecular characterization of the family of the N-methyl-D-aspartate receptor subunits.
1993,
Pubmed
,
Xenbase
Jang,
A steroid modulatory domain on NR2B controls N-methyl-D-aspartate receptor proton sensitivity.
2004,
Pubmed
,
Xenbase
Kalia,
NMDA receptors in clinical neurology: excitatory times ahead.
2008,
Pubmed
Kaplan,
The use of cognitive enhancers in animal models of fear extinction.
2011,
Pubmed
Káradóttir,
NMDA receptors are expressed in oligodendrocytes and activated in ischaemia.
2005,
Pubmed
Karakas,
Crystal structure of a heterotetrameric NMDA receptor ion channel.
2014,
Pubmed
Karavanova,
Novel regional and developmental NMDA receptor expression patterns uncovered in NR2C subunit-beta-galactosidase knock-in mice.
2007,
Pubmed
Kostakis,
A steroid modulatory domain in NR2A collaborates with NR1 exon-5 to control NMDAR modulation by pregnenolone sulfate and protons.
2011,
Pubmed
,
Xenbase
Krystal,
Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses.
1994,
Pubmed
Laube,
Molecular determinants of agonist discrimination by NMDA receptor subunits: analysis of the glutamate binding site on the NR2B subunit.
1997,
Pubmed
Laurie,
The distribution of splice variants of the NMDAR1 subunit mRNA in adult rat brain.
1995,
Pubmed
Laurie,
Regional and developmental heterogeneity in splicing of the rat brain NMDAR1 mRNA.
1994,
Pubmed
Lee,
NMDA receptor structures reveal subunit arrangement and pore architecture.
2014,
Pubmed
,
Xenbase
Lisman,
Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia.
2008,
Pubmed
Lisman,
Excitation, inhibition, local oscillations, or large-scale loops: what causes the symptoms of schizophrenia?
2012,
Pubmed
Lu,
NMDA receptor subtypes at autaptic synapses of cerebellar granule neurons.
2006,
Pubmed
Malayev,
Inhibition of the NMDA response by pregnenolone sulphate reveals subtype selective modulation of NMDA receptors by sulphated steroids.
2002,
Pubmed
,
Xenbase
Micu,
NMDA receptors mediate calcium accumulation in myelin during chemical ischaemia.
2006,
Pubmed
Monaghan,
Pharmacological modulation of NMDA receptor activity and the advent of negative and positive allosteric modulators.
2012,
Pubmed
Monyer,
Developmental and regional expression in the rat brain and functional properties of four NMDA receptors.
1994,
Pubmed
Mosley,
Quinazolin-4-one derivatives: A novel class of noncompetitive NR2C/D subunit-selective N-methyl-D-aspartate receptor antagonists.
2010,
Pubmed
,
Xenbase
Mott,
Open probability of homomeric murine 5-HT3A serotonin receptors depends on subunit occupancy.
2001,
Pubmed
,
Xenbase
Mullasseril,
A subunit-selective potentiator of NR2C- and NR2D-containing NMDA receptors.
2010,
Pubmed
Norberg,
A meta-analysis of D-cycloserine and the facilitation of fear extinction and exposure therapy.
2008,
Pubmed
Ogden,
New advances in NMDA receptor pharmacology.
2011,
Pubmed
Ogden,
Contribution of the M1 transmembrane helix and pre-M1 region to positive allosteric modulation and gating of N-methyl-D-aspartate receptors.
2013,
Pubmed
,
Xenbase
Olney,
NMDA receptor hypofunction model of schizophrenia.
1999,
Pubmed
Petrovic,
20-oxo-5beta-pregnan-3alpha-yl sulfate is a use-dependent NMDA receptor inhibitor.
2005,
Pubmed
Preskorn,
An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-D-aspartate antagonist, CP-101,606, in patients with treatment-refractory major depressive disorder.
2008,
Pubmed
Prybylowski,
Increased exon 5 expression alters extrasynaptic NMDA receptors in cerebellar neurons.
2000,
Pubmed
Qian,
NR2 subunit-dependence of NMDA receptor channel block by external Mg2+.
2005,
Pubmed
Rumbaugh,
Exon 5 and spermine regulate deactivation of NMDA receptor subtypes.
2000,
Pubmed
Sali,
Comparative protein modelling by satisfaction of spatial restraints.
1993,
Pubmed
Salter,
NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury.
2005,
Pubmed
Sastry,
Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments.
2013,
Pubmed
Sheinin,
Subunit specificity and mechanism of action of NMDA partial agonist D-cycloserine.
2001,
Pubmed
,
Xenbase
Siegler Retchless,
A single GluN2 subunit residue controls NMDA receptor channel properties via intersubunit interaction.
2012,
Pubmed
Suryavanshi,
GluN2C/GluN2D subunit-selective NMDA receptor potentiator CIQ reverses MK-801-induced impairment in prepulse inhibition and working memory in Y-maze test in mice.
2014,
Pubmed
Traynelis,
Glutamate receptor ion channels: structure, regulation, and function.
2010,
Pubmed
Traynelis,
Control of voltage-independent zinc inhibition of NMDA receptors by the NR1 subunit.
1998,
Pubmed
,
Xenbase
Traynelis,
Control of proton sensitivity of the NMDA receptor by RNA splicing and polyamines.
1995,
Pubmed
,
Xenbase
Ulbrich,
Subunit counting in membrane-bound proteins.
2007,
Pubmed
,
Xenbase
Vance,
Ligand-specific deactivation time course of GluN1/GluN2D NMDA receptors.
2011,
Pubmed
Vance,
GluN1 splice variant control of GluN1/GluN2D NMDA receptors.
2012,
Pubmed
,
Xenbase
Watanabe,
Developmental changes in distribution of NMDA receptor channel subunit mRNAs.
1992,
Pubmed
Wenzel,
NMDA receptor heterogeneity during postnatal development of the rat brain: differential expression of the NR2A, NR2B, and NR2C subunit proteins.
1997,
Pubmed
Williams,
Developmental switch in the expression of NMDA receptors occurs in vivo and in vitro.
1993,
Pubmed
,
Xenbase
Wu,
Targeting the NMDA receptor subunit NR2B for the treatment of neuropathic pain.
2009,
Pubmed
Yuan,
Control of NMDA receptor function by the NR2 subunit amino-terminal domain.
2009,
Pubmed
,
Xenbase
Zhu,
Allosteric signaling and dynamics of the clamshell-like NMDA receptor GluN1 N-terminal domain.
2013,
Pubmed
Zimmerman,
Design, synthesis, and structure-activity relationship of a novel series of GluN2C-selective potentiators.
2014,
Pubmed
,
Xenbase
